BIROn - Birkbeck Institutional Research Online
    Up a level
    Export as [feed] Atom [feed] RSS
    Jump to: 2003 | 2006 | 2011 | 14 April 2021
    Number of items: 4.

    2003

    Hockly, E. and Richon, V.M. and Woodman, B. and Smith, D.L. and Zhou, X.B. and Rosa, E. and Sathasivam, K. and Ghazi-Noori, S. and Mahal, A. and Lowden, Philip and Steffan, J.S. and Marsh, J.L. and Thompson, L.M. and Lewis, C.M. and Marks, P.A. and Bates, G.P. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America 100 (4), pp. 2041-2046. ISSN 0027-8424.

    2006

    Hockly, E. and Tse, J. and Barker, A.L. and Moolman, D.L. and Beunard, Jean-Luc and Revington, Adrian P. and Holt, K. and Sunshine, S. and Moffitt, H. and Sathasivam, K. and Woodman, B. and Wanker, E.E. and Lowden, Philip A.S. and Bates, G.P. (2006) Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease. Neurobiology of Disease 21 (1), pp. 228-236. ISSN 0969-9961.

    2011

    Taylor, D.M. and Balabadra, U. and Xiang, Z. and Woodman, B. and Meade, S. and Amore, A. and Maxwell, M.M. and Reeves, S. and Bates, G.P. and Luthi-Carter, R. and Lowden, Philip A.S. and Kazantsev, A.G. (2011) A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of Sirtuin 2 Deacetylase. ACS Chemical Biology 6 (6), pp. 540-546. ISSN 1554-8929.

    14 April 2021

    Zhou, Y. and Peskett, T.R. and Landles, C. and Warner, J.B. and Sathasivam, K. and Smith, E.J. and Chen, S. and Wetzel, R. and Lashuel, H.A. and Bates, G.P. and Saibil, Helen R. (2021) Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington’s disease. Acta Neuropathologica Communications 9 (1), ISSN 2051-5960.

    This list was generated on Wed Dec 1 18:18:35 2021 GMT.